Checkpoint-Inhibitoren beim malignen Melanom: Rheumatologische Symptome beherrschen
Author:
Publisher
Deutscher Arzte-Verlag GmbH
Reference33 articles.
1. Farhood B, Najafi M, Mortezaee K: CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review. J Cell Physiol Juni 2019; 234 (6): 8509–21. DOI: 10.1002/jcp.27782. Epub 22. November 2018. PMID: 30520029.
2. Topalian SL, Drake CG, Pardoll DM: Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 13. April 2015; 27 (4): 450–61. DOI: 10.1016/j.ccell.2015.03.001. Epub 6. April 2015. PMID: 25858804; PMCID: PMC4400238.
3. Wei SC, Duffy CR, Allison JP: Fundamental Mechanisms of Immune Checkpoint Blockade Therapy. Cancer Discov September 2018; 8 (9): 1069–86. DOI: 10.1158/2159–8290.CD-18–0367. Epub 16. August 2018. PMID: 30115704.
4. Galon J, Angell HK, Bedognetti D, Marincola FM: The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. Immunity 25. Juli 2013; 39 (1): 11–26. DOI: 10.1016/j.immuni.2013.07.008. PMID: 23890060.
5. Hirsch L, Zitvogel L, Eggermont A, Marabelle A: PD-Loma: a cancer entity with a shared sensitivity to the PD-1/PD-L1 pathway blockade. Br J Cancer Januar 2019; 120 (1): 3–5. DOI: 10.1038/s41416–018–0294–4. Epub 9. November 2018. PMID: 30413824; PMCID: PMC6325162.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3